Review of clinical approaches in fluorescence lifetime imaging ophthalmoscopy
- 4 September 2018
- journal article
- conference paper
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 23 (09) , 091415-20
Abstract
Fluorescence lifetime imaging ophthalmoscopy (FLIO) is an imaging modality that can be used to investigate the human fundus in vivo. In contrast to commonly used autofluorescence-based imaging modalities, the information obtained with FLIO is not based only on the intensity of individual fluorophores. As the main outcome measure, autofluorescence lifetimes (also called autofluorescence decay times) are investigated; these are independent of the fluorescence intensity and may be correlated to changes in the molecular composition of the human retina. Although the technique is relatively new, many diseases have already been investigated. Researchers have discovered very specific disease-related changes, which could be helpful in the early diagnosis as well as the follow-up of different diseases. This review article aims to give an overview of the clinical applications of FLIO. This may be helpful to establish the use of FLIO in the clinical routine. After briefly explaining the methodology of the FLIO technique, different clinical applications will be emphasized. This review includes a detailed description of FLIO findings in the healthy eye, as well as age-related macular degeneration (AMD), diabetic retinopathy (DR), macular telangiectasia type 2 (MacTel), albinism, retinal vessel occlusion, Stargardt disease, central serous chorioretinopathy (CSCR), choroideremia, retinitis pigmentosa (RP), and Alzheimer’s disease. Furthermore, mouse models will only briefly be discussed, as they may eventually help in understanding the contribution of single fundus layers to the sum fluorescence. They may help to interpret fluorescence changes in relationship to pathomechanisms behind different diseases. Finally, we will discuss the current state of FLIO research and try to give an outlook from our own perspective on possible future significances of the FLIO methodology.Keywords
Funding Information
- Lowy Medical Research Institute
- National Institutes of Health (EY11600)
- National Institutes of Health (EY14800)
This publication has 243 references indexed in Scilit:
- The bisretinoids of retinal pigment epitheliumProgress in Retinal and Eye Research, 2012
- Fluorescence Lifetime Techniques in Medical ApplicationsAnnals of Biomedical Engineering, 2012
- The Prevalence of Macular Telangiectasia Type 2 in the Beaver Dam Eye StudyAmerican Journal of Ophthalmology, 2010
- The pivotal role of the complement system in aging and age-related macular degeneration: Hypothesis re-visitedProgress in Retinal and Eye Research, 2010
- Familial Asymptomatic Macular Telangiectasia Type 2Ophthalmology, 2009
- Fundus Autofluorescence in Type 2 Idiopathic Macular Telangiectasia: Correlation with Optical Coherence Tomography and MicroperimetryAmerican Journal of Ophthalmology, 2009
- Retinal carotenoids can attenuate formation of A2E in the retinal pigment epitheliumArchives of Biochemistry and Biophysics, 2009
- Perspective on Genes and Mutations Causing Retinitis PigmentosaArchives of Ophthalmology (1950), 2007
- Vertebrate and invertebrate carotenoid-binding proteinsArchives of Biochemistry and Biophysics, 2007
- The Prevalence of Age-Related Macular Degeneration and Associated Risk FactorsArchives of Ophthalmology (1950), 2001